Fingerprint
Dive into the research topics of 'Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically